SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 107 filers reported holding SYROS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.79 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $7,000 | -22.2% | 7,500 | -17.0% | 0.00% | – |
Q1 2022 | $9,000 | -70.0% | 9,041 | -5.3% | 0.00% | – |
Q4 2021 | $30,000 | -33.3% | 9,550 | -7.2% | 0.00% | – |
Q3 2021 | $45,000 | -58.7% | 10,289 | -49.4% | 0.00% | – |
Q2 2021 | $109,000 | -67.1% | 20,344 | -54.2% | 0.00% | -100.0% |
Q1 2021 | $331,000 | +1404.5% | 44,408 | +2011.7% | 0.00% | – |
Q4 2020 | $22,000 | -86.7% | 2,103 | -88.8% | 0.00% | – |
Q3 2020 | $165,000 | +73.7% | 18,747 | +109.3% | 0.00% | – |
Q2 2020 | $95,000 | +691.7% | 8,959 | +325.4% | 0.00% | – |
Q1 2020 | $12,000 | -96.4% | 2,106 | -93.7% | 0.00% | -100.0% |
Q4 2017 | $330,000 | +148.1% | 33,418 | +270.3% | 0.00% | – |
Q3 2017 | $133,000 | – | 9,025 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 3,439,895 | $18,747,000 | 4.66% |
Bain Capital Life Sciences Investors, LLC | 5,785,036 | $31,528,000 | 2.07% |
Omega Fund Management, LLC | 2,274,831 | $12,398,000 | 1.40% |
Altium Capital Management LP | 1,076,942 | $5,869,000 | 1.36% |
Samsara BioCapital, LLC | 2,189,199 | $10,599,000 | 1.31% |
Sio Capital Management, LLC | 800,000 | $4,360,000 | 1.08% |
Flagship Pioneering Inc. | 2,938,494 | $16,015,000 | 0.20% |
EcoR1 Capital, LLC | 1,000,000 | $5,450,000 | 0.20% |
Artal Group S.A. | 1,700,000 | $9,265,000 | 0.19% |
ACT CAPITAL MANAGEMENT, LLC | 52,500 | $287,000 | 0.15% |